Marathon Trading Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Marathon Trading Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-198	Closed	-$12K	–	285
2026 Q1	$12K	Buy	+198	New	+$11.5K	﹤0.01%	258
2024 Q1	–	Sell	-22,373	Closed	-$1.15M	–	372
2023 Q4	$1.15M	Buy	+22,373	New	+$1.17M	0.06%	160
2020 Q1	–	Sell	-115,247	Closed	-$7.4M	–	153
2019 Q4	$7.4M	Buy	115,247 +106,247	+1,181%	+$6.08M	0.5%	29
2019 Q3	$456K	Buy	+9,000	New	+$423K	0.08%	135
2019 Q2	–	Sell	-64,827	Closed	-$3.09M	–	227
2019 Q1	$3.09M	Buy	+64,827	New	+$3.23M	0.36%	57
2016 Q4	–	Sell	-28,250	Closed	-$1.54M	–	148
2016 Q3	$1.52M	Buy	+28,250	New	+$1.81M	0.21%	53
2015 Q2	–	Sell	-4,519	Closed	-$291K	–	454
2015 Q1	$291K	Sell	4,519 -283,281	-98%	-$17.7M	0.02%	393
2014 Q4	$17M	Buy	+287,800	New	+$16.2M	0.24%	55

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Marathon Trading Investment Management's BMY Position: Q2 2026 in Review

Marathon Trading Investment Management sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 198 shares — an estimated $12K sold.

Marathon Trading Investment Management first reported a position in BMY in Q4 2014 and held it in 8 quarters. The position peaked at $17M in Q4 2014. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Marathon Trading Investment Management reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
Marathon Trading Investment Management sold 198 Bristol-Myers Squibb shares in Q2 2026, an estimated $12K.
Marathon Trading Investment Management first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 8 quarters.
Marathon Trading Investment Management's Bristol-Myers Squibb position peaked at $17M in Q4 2014.
2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Marathon Trading Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.